**Core Concept**
Immune-mediated qualitative drug intolerance refers to a condition where the immune system produces antibodies that alter the drug's pharmacokinetics, resulting in altered efficacy or increased toxicity. This occurs due to changes in the drug's metabolism, distribution, or excretion, often affecting the drug's target or receptor.

**Why the Correct Answer is Right**
The correct answer involves the concept of immunogenicity, where the immune system recognizes the drug as foreign, leading to the production of antibodies that bind to the drug. This binding can alter the drug's pharmacokinetics, resulting in altered efficacy or increased toxicity. The production of these antibodies is often a result of changes in the drug's structure, which can occur due to various factors such as chemical modifications or genetic polymorphisms.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it refers to a different type of drug intolerance.
**Option B:** This option is incorrect because it is a common side effect of many medications, but not specifically related to immune-mediated qualitative drug intolerance.
**Option C:** This option is incorrect because it refers to a condition where the immune system produces antibodies against the drug, but it is not the correct term for immune-mediated qualitative drug intolerance.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that immune-mediated qualitative drug intolerance can occur with any medication, and it's often related to genetic polymorphisms or changes in the drug's structure. This can result in altered efficacy or increased toxicity, making it crucial to monitor patients closely for signs of intolerance.

**Correct Answer:** A. Allergic drug reaction